choline has been researched along with Osteosarcoma in 5 studies
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lamego, I | 2 |
Duarte, IF | 2 |
Marques, MP | 2 |
Gil, AM | 2 |
Marques, J | 1 |
Blaise, BJ | 1 |
Gosling, M | 1 |
Smith, JW | 1 |
Poyner, DR | 1 |
Li, YP | 1 |
Baskin, F | 1 |
Davis, R | 1 |
Hersh, LB | 1 |
Singh, AT | 1 |
Radeff, JM | 1 |
Kunnel, JG | 1 |
Stern, PH | 1 |
5 other studies available for choline and Osteosarcoma
Article | Year |
---|---|
Metabolic markers of MG-63 osteosarcoma cell line response to doxorubicin and methotrexate treatment: comparison to cisplatin.
Topics: Amino Acids; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cell Membrane; Choline; Cis | 2014 |
Nuclear magnetic resonance (NMR) study of the effect of cisplatin on the metabolic profile of MG-63 osteosarcoma cells.
Topics: Alcohols; Amino Acids; Choline; Cisplatin; Humans; Kinetics; Lipids; Magnetic Resonance Spectroscopy | 2010 |
Characterization of a volume-sensitive chloride current in rat osteoblast-like (ROS 17/2.8) cells.
Topics: Animals; Calcium; Calcium Channel Blockers; Cell Membrane Permeability; Chloride Channels; Choline; | 1995 |
Cholinergic neuron-specific expression of the human choline acetyltransferase gene is controlled by silencer elements.
Topics: Animals; Choline; Choline O-Acetyltransferase; Gene Expression Regulation; Humans; Neuroblastoma; Ne | 1993 |
Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells.
Topics: Antineoplastic Agents; Bone Neoplasms; Bridged-Ring Compounds; Choline; Down-Regulation; Drug Synerg | 2000 |